Lyka Labs Limited (LYKALABS) — Announcement | 11 August 2026
Lyka Labs Limited issued a revised press release correcting typographical errors in its unaudited Q1 FY27 financial results, which showed revenue growth but declining EBITDA margins and significant profit increases year-on-year. The revision updates key figures without altering underlying performance trends.
About Lyka Labs Limited (LYKALABS)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when LYKALABS files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track LYKALABS — Free💡 Ask AI about this filing
📊 More LYKALABS filings
- Announcement — 24 September 2026Lyka Labs Ltd announced that its trading window will close on 1 October 2026 for 48 hours following ...
- 🟡 Board Meeting — 10 August 2026Lyka Labs Limited announced the board approved unaudited Q1 FY26 financial results and the divestmen...
- 🟡 Board Meeting — 10 August 2026Lyka Labs Limited held its 47th Annual General Meeting on 10 August 2026 via video conference, with ...
- 🔴 Financial Results — 10 August 2026Lyka Labs Limited reported Q1 FY27 consolidated net total income of **₹4,272.79 crores**, up 26.95% ...
- share transfer — 10 July 2026Lyka Labs Limited received a SEBI-mandated certificate from MUFG Intime India confirming demateriali...
🔥 Also filed on 11 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when LYKALABS files new disclosures
Track LYKALABS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track LYKALABS — FreeFree account · 2 AI queries/day